HomeLab TestAnti SS-A. SS-B Antibodies
Overview
SSA or Ro is composed of protein antigens of 52 kDa and 60 kDa combined with cytoplasmic RNA species. SSA antibodies occur in patients with several different connective tissue diseases including Sjogren syndrome, an autoimmune disease that involves p...
Risk assessment
Risk Assessment:
- Sjögren’s Syndrome: Characterized by dry eyes, mouth, and other mucosal surfaces.
- Systemic Lupus Erythematosus (SLE): An autoimmune disease that can affect multi...
Ranges
Normal Range:
- Anti-SS-A (Ro): Negative (varies depending on the laboratory, but typically < 20 U/mL).
- Anti-SS-B (La): Negative (similar to SS-A, generally < 20 U/mL).
No...
Test result interpretation
Interpretation:
- Positive Result: Suggests the presence of an autoimmune disorder, such as Sjögren’s syndrome, lupus, or other connective tissue diseases.
- Negative Result: Does no...
Sample types
Sample Type:
- Blood Sample: The test is typically performed on a serum sample obtained from a blood draw.
Frequently Asked Questions
What are anti-SS-A and anti-SS-B antibodies?
Why is the anti-SS-A and anti-SS-B antibodies test performed?
Who should undergo the anti-SS-A and anti-SS-B antibodies test?
What symptoms are associated with conditions detected by anti-SS-A and anti-SS-B antibodies?
How is the test performed?
What do the results of the test indicate?
Are there any limitations to the test?
Can anti-SS-A and anti-SS-B antibodies be treated?
What should I do if my test results are positive?
Anti SS-A. SS-B Antibodies
Unveiling Health Insights with Anti SS-A and SS-B Antibody Testing
Includes 1 Test
৳4500
৳500010% OFF
Report in 12 hours
Booked 0 times
Sample Type:
blood
Fasting Required:
No
Description
SSA or Ro is composed of protein antigens of 52 kDa and 60 kDa combined with cytoplasmic RNA species. SSA antibodies occur in patients with several different connective tissue diseases including Sjogren syndrome, an autoimmune disease that involves primarily the salivary and lachrymal glands (up to 90% of cases); systemic lupus erythematosus (SLE) (40%-60% of cases); and rheumatoid arthritis.